微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 4.14% | -13.21% | 100.97% | 72/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 2.06% | 15.73% | 79.13% | 82/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.15% | -23.84% | -79.43% | 88/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 5.59% | 116.67% | 17.19% | 59/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 4.77% | 56.39% | 167.98% | 74/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.78% | -1.66% | 17.88% | 89/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.51% | -7.93% | -41.47% | 72/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 2.58% | 104.76% | -15.41% | 95/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 3.05% | 376.56% | 68.51% | 84/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 1.81% | 56.03% | 10.37% | 92/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.64% | 69.07% | 30.16% | 70/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 1.26% | 223.08% | 96.88% | 105/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 0.64% | 3100% | -44.83% | 115/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 1.16% | -52.85% | 19.59% | 108/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 0.97% | 286.54% | 148.72% | 95/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 0.39% | -87.85% | 1850% | 108/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 0.02% | -99.57% | -99.19% | 100/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 2.46% | -15.17% | 573.08% | 82/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | -0.52% | -133.33% | -116.2% | 91/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 3.21% | 134.31% | -31.12% | 102/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 4.66% | -25.32% | 60.69% | 70/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 2.9% | -31.6% | 85.9% | 74/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.56% | -26.42% | 13.87% | 66/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 1.37% | -71.58% | -78.04% | 114/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 6.24% | 84.07% | 47.17% | 53/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 4.24% | 202.86% | 100% | 54/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.12% | 351.06% | -56.02% | 51/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 4.82% | 1083.67% | 42.18% | 86/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 3.39% | 1155.56% | 142.14% | 73/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 1.4% | 766.67% | 197.87% | 88/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.47% | 361.11% | 195.92% | 76/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | -0.49% | 96.78% | -281.48% | 107/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 0.27% | 103.1% | 228.57% | 78/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | -0.21% | 93.9% | -16.67% | 83/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | -0.18% | 84.62% | 98.82% | 76/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | -15.24% | -3363.64% | -75.17% | 102/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | -8.7% | -327.15% | -152.91% | 76/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | -3.44% | -413.43% | -194.02% | 79/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | -1.17% | -128.13% | -165.91% | 72/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |